biote Corp.
BTMD · XNASCIK 1819253fmd_0MR6C7067YJXCF06ZCDV4NCEK4Manufacturing · Medicinal Chemicals & Botanical ProductsTemplate: Standard
Coverage: Jan 02, 2020 to Sep 30, 2026, 25 periods
| Line item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Total revenues | 139 | 165 | 185 | 197 | 192 |
| Selling, general and administrative | 49 | 171 | 99 | 107 | 102 |
| Operating income | 35 | (61) | 29 | 32 | 36 |
| Other non-operating income (expense) | (2) | 62 | (29) | (31) | 2 |
| Income before taxes | 33 | 2 | (0) | 1 | 38 |
| Income tax expense | 0 | 0 | 3 | 1 | 6 |
| Net income from continuing operations | 33 | 1 | (3) | 0 | 32 |
| Net income | 11 | (1) | 3 | 3 | 27 |
| Net income to common shareholders | – | (1) | 3 | 3 | 27 |